Analysis of the Intracellular Transport Properties of Recombinant La Crosse Virus Glycoproteins  by BUPP, KEITH et al.
VIROLOGY 220, 485–490 (1996)
ARTICLE NO. 0336
SHORT COMMUNICATION
Analysis of the Intracellular Transport Properties of Recombinant
La Crosse Virus Glycoproteins
KEITH BUPP, KARA STILLMOCK, and FRANCISCO GONZA´LEZ-SCARANO1
Departments of Neurology and Microbiology, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104-6146
Received December 13, 1995; accepted April 15, 1996
The G1 and G2 glycoproteins of La Crosse virus, a member of the Bunyavirus genus of the Bunyaviridae, are encoded
as a single open reading frame (ORF) in the viral middle-sized RNA segment. The primary product from this ORF is processed,
either cotranslationally or shortly after translation, into the two glycoproteins and a nonstructural protein, NSm, of unknown
function. We have expressed La Crosse glycoproteins using vaccinia vectors and studied their processing and localization.
When expressed in the native G2-NSm-G1 configuration, both G1 and G2 targeted to the Golgi apparatus as shown by their
colocalization with wheat germ agglutinin and acquired resistance to endoglycosidase H. When expressed independently,
G2 was targeted to the Golgi apparatus but G1 was retained in the endoplasmic reticulum, indicating that a G1–G2
association is required for Golgi targeting of G1. In contrast to results with other members of the Bunyaviridae, we found
that expression of G1 and G2 from separate vectors did not lead to the transport of the G1–G2 complex to the Golgi.
However, disruption of the NSm region with a foreign sequence did not interfere with transport of the complex. When a
portion of the b-galactosidase gene was inserted in frame into NSm, the glycoproteins derived from this construct were
processed and targeted properly and were capable of mediating cell-to-cell fusion. q 1996 Academic Press, Inc.
La Crosse virus is a member of the Bunyavirus genus calization to the Golgi for the glycoprotein that would
otherwise remain in the endoplasmic reticulum (ER).of the family Bunyaviridae. A common feature of the Buny-
aviridae is the presence of two spike glycoproteins, con- We have expressed the La Crosse glycoproteins either
together or independently using vaccinia vectors andventionally named according to size as G1 and G2, that
are derived from a single open reading frame (ORF) en- show that the G2 glycoprotein of La Crosse virus is re-
sponsible for Golgi targeting of the presumed hetero-coded in the medium-sized (or M) RNA segment of the
segmented negative-strand genome. However, the size dimer. When expressed independently, G1 was retained
in the ER, but G2 was targeted to the Golgi. In contrastof the glycoproteins and their location on the ORF varies
among the genera, and even within a genus (1). Cleavage to results with other members of the Bunyaviridae, we
found that independent expression of G1 and G2 fromof the precursor generally occurs either during or rapidly
after translation. Among the Bunyaviridae, precursor pro- separate vectors did not result in the transport of a G1–
G2 complex to the Golgi apparatus. However, we didteins produced by translation of the ORF have only been
detected in members of the Nairovirus genus (2). Once find that insertion of a foreign peptide sequence into
NSm had no effect on glycoprotein processing, targeting,the polyprotein is cleaved, G1 and G2 are thought to
associate as a heterodimer which is then transported to or ability to mediate cell-to-cell fusion.
The La Crosse virus M segment ORF and its deriva-the Golgi apparatus where viral budding takes place (3–
5). When G1 and G2 are expressed independently of tives were expressed using a vaccinia virus expression
system, as previously described (12). The La Crosse-each other, the resulting glycoprotein localization varies
depending on the virus (6–11). In addition, in several specific coding regions of these constructs are shown
in Fig. 1. Recombinant VV.ORF encodes the entire Minstances investigators have demonstrated that covalent
linkage between G1 and G2 through the primary transla- segment polyprotein in its native configuration. VV.G1
encodes 145 (of 174) amino acids of NSm followed bytion product is not required for Golgi targeting (6–8, 10,
11). Expression from separate vectors still results in lo- G1 (12). Recombinant VV.G2 encodes the signal se-
quence and coding portion of G2 followed immediately
by a termination codon (13). VV.MLacZ contains 641 To whom correspondence and reprint requests should be ad-
amino acids of the a-peptide of the b-galactosidase genedressed at Department of Neurology, University of Pennsylvania, Clini-
plus an additional methionine residue inserted betweencal Research Building, 415 Curie Boulevard, Philadelphia, PA 19104-
6146. Fax: (215) 573-2029. amino acids 29 and 30 of NSm.
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pattern of endoH resistance of G1 in the VV.ORF-infected
cells was similar to that of G1 from LAC-infected cells
(Fig. 3, left) or sucrose density purified virions (not
shown). G2 also acquired significant resistance to endoH
(Fig. 3, right) with a pattern that resembled that of G2
from isolated virions. Neither pattern changed after an
unlabeled overnight chase (not shown).
The vaccinia recombinant VV.G2, which expresses G2
independently of G1, generated a protein that migrated
by SDS–PAGE at approximately the same position as
G2 from either La Crosse virus or VV.ORF (Fig. 3, right),
FIG. 1. La Crosse virus M segment protein coding regions of recom-
although the band was consistently somewhat more dif-binant vaccinia viruses. The G2 coding region is shaded, the NSm
fuse. Like the native G2, G2 expressed from VV.G2 dem-region is white, and the G1 coding region is denoted by diagonal lines.
The b-galactosidase insertion in VV.MLacZ is indicated by horizontal onstrated a cellular distribution in IFA that overlapped
lines. The scale above the constructs indicates the length in amino that of WGA (Fig. 4, right panels). No G2 was detected
acids. Construction of the vaccinia recombinants VV.ORF and VV.G1 on the surface of VV.G2-infected cells. EndoH treatment
has been described (12). VV.G2 and VV.MLacZ were similarly prepared
of the immunoprecipitated proteins showed that G2 didby inserting La Crosse M segment sequences into the BglII site of a
acquire resistance to the glycosidase (Fig. 3, right), butpSC11 derivative. The G2 portion was amplified from pM.ORF (12)
using VENT DNA polymerase (New England Biolabs) and the following in all of the viruses there was still a clear endoH-sensitive
primers: 5*GAAGATCTTAACGTTTGAATATTAAAGTT3* and 5*GAAGAT- band that did not disappear after an overnight chase (not
CTTTATCTGGCAGCTCTTAGGCTTTT3*. To create VV.MLacZ a portion
shown). This band migrated faster when the protein hadof the a-peptide of b-galactosidase was amplified from pUC19 using
been expressed from VV.G2 compared with the G2 fromthe following primers: 5*CATGCCATGGCCGTCGTTTTACAACG3* and
5*CATGCCATGGCATCAGAGCAGATTG3*. The product was digested either VV.ORF or La Crosse virus and the difference in
with NcoI and ligated into the unique NcoI site in the NSm region. mobility remained even after endoglycosidase F treat-
ment. This indicates that the difference in mobility was
not due to N-linked glycosylation. To ensure that these
The subcellular localization of G1 and G2 expressed results did not reflect an unexpected truncation, DNA
from La Crosse virus or various vaccinia recombinants from VV.G2 was amplified by PCR using the primers used
was compared with the distribution of wheat germ agglu-
to construct VV.G2 and the size of the product compared
tinin (a late Golgi marker (14)) using confocal microscopy.
with that of G2 amplified from the original plasmid encod-
This provided high-resolution images of optical sections
ing a cDNA of the M RNA. These both showed the ex-
through the cells. As expected, La Crosse-infected cells
pected 954-bp band (not shown). Sequence analysisdemonstrated a perinuclear distribution of G1 and G2
showed that there were no mutations introduced due tothat overlapped the distribution of wheat germ agglutinin
PCR amplification. Taken together, these results indicate(WGA) (Fig. 2), indicating that the two glycoproteins were
that G2 can be transported to the Golgi in the absencetargeted to the Golgi. However, although the distributions
of G1 but that the structure of G2 is slightly altered, per-were overlapping, they were not identical. Regions posi-
haps by O-linked glycosylation.tive for G1 or G2 but negative for WGA are presumably
In contrast, when G1 was expressed independently ofearly Golgi compartments and those regions positive for
G2, it did not colocalize with WGA (Fig. 4, left panels).WGA but negative for G1 or G2 are likely to be endo-
Instead, anti-G1 immunofluorescence showed a reticularsomes (15). The perinuclear distributions of G1 and G2
pattern distributed throughout the cytoplasm which wasin VV.ORF-infected cells were very similar to their distri-
reminiscent of the endoplasmic reticulum (17). In cellsbutions in La Crosse-infected cells as is also shown in
infected with VV.G1, G1 remained endoH sensitive (Fig.Fig. 2. As reported previously (12), some of the glycopro-
3, left), even after a 16-hr chase (not shown), confirmingteins expressed from VV.ORF are also detected on the
the ER distribution visualized by IFA. Several experimentscell surface. However, G1 remains localized to the Golgi
in which cells were coinfected with VV.G1 and VV.G2region even after a 3-hr chase in the presence of 50 mg/
resulted in a similar pattern for G1, even when both vi-ml cycloheximide (not shown). This is consistent with its
ruses were added at maximal concentrations (m.o.i. 10,slow rate of transport to the cell surface in La Crosse-
not shown). Virtually all cells showed positive G2 staininginfected cells (16).
and greater than 50% gave a G1 signal. Under thoseIn order to confirm that the localizations of G1 and G2
conditions, G1 also remained endoH sensitive (data notseen in IFA corresponded to Golgi targeting, we per-
shown). These results demonstrate a possible require-formed endoglycosidase H (endoH) digestions on immu-
ment for covalent linkage between G1 and G2 duringnoprecipitated, radiolabeled proteins. In cells infected
translation for appropriate G1 targeting to the Golgi. Al-with either La Crosse virus or VV.ORF, G1 became par-
tially resistant to digestion with endoH (Fig. 3, left). The ternatively, the aberrant migration of G2 from VV.G2 may
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FIG. 2. Colocalization of La Crosse (LAC) glycoproteins with wheat germ agglutinin (WGA). HeLa cells were infected with the indicated viruses
at m.o.i.  1 for 16 hr and then fixed in 95% ethanol/5% acetic acid at 0207. They were then costained with rhodamine-conjugated WGA and either
an anti-G1 monoclonal antibody mixture (807.25, 807.33, and 807.35 (22)) or an anti-G2 monoclonal (4A5.5, 9B7.5, or 9E7.2 (23)) as indicated. On
the left, cells infected with La Crosse virus were fixed and costained using anti-G1 antibodies (top) and WGA (bottom). G2 also colocalized with
WGA (not shown). On the right, cells were infected with VV.ORF and costained using an anti-G2 antibody (top) and WGA(bottom). G1 also colocalized
with WGA (not shown).
be indicative of a structural alteration inhibiting its inter- expressed from VV.MLacZ (Fig. 1). As shown in Fig. 5,
both G1 and G2 were targeted to the Golgi apparatus.action with G1.
The region between G2 and G1 in the M RNA ORF The glycoproteins from this construct were also indistin-
guishable from those expressed from VV.ORF when com-encodes a nonstructural protein (NSm) of unknown func-
tion. To determine the effect of disruption of the NSm pared by endoH digestion (not shown). The presence of
the b-galactosidase insertion in vaccinia was confirmedsequence on the pattern of Golgi targeting of G1 and
G2, we studied the properties of these proteins when by PCR analysis of viral DNA.
FIG. 3. (Left) G1 expressed from La Crosse or VV.ORF acquires endoH resistance but remains endoH sensitive when expressed from VV.G1.
HeLa cells were infected with the indicated viruses at m.o.i.  5 for 2 hr in Cys/Met-free medium and then for 6 hr in the same medium containing
an 35S-Cys/Met mixture. Cells were then lysed using 0.5% NP-40 and G1 (MW, 125 kDa) was precipitated using the anti-G1 monoclonal antibody
mixture and protein A–Sepharose beads coated with goat anti-mouse antiserum. The proteins were then treated (/) or not treated (0) with endoH,
eluted by boiling in SDS–sample buffer, and separated on a 10% polyacrylamide gel. A shorter exposure revealed that the endoH digestion products
of G1 from La Crosse-infected cells were similar to those from VV.ORF-infected cells (not shown). (Right) G2 expressed either in the presence or
in the absence of G1 acquires endoH resistance. Radiolabeling, immunoprecipitation, and endoH treatment of G2 from cells infected with the
indicated vaccinia constructs were carried out as above using an anti-G2 monoclonal antibody except that cells were labeled with [35S]cysteine.
The endoH digestion product of G2 from purified La Crosse virions is also shown as a control. The size of undigested G2 is 39 kDa. The size of
the endoH-sensitive product from LAC virions or VV.ORF is 36 kDa (dots) and from VV.G2 is 32 kDa (asterisk).
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FIG. 4. Comparison of G1 and G2 localization with WGA distribution when each glycoprotein is expressed independently of the other. Cells
infected with the indicated recombinant vaccinia viruses were fixed and stained as described in Fig. 2. As shown in the left panels, when G1 is
expressed independently of G2 (from VV.G1), it is more diffusely distributed in a reticular pattern throughout the cytoplasm than is WGA. The cell
on the right which is stained with WGA but not anti-G1 is apparently uninfected. In contrast, G2 expressed from VV.G2 (right panels) colocalizes
with WGA, demonstrating that by itself it can be targeted to the Golgi apparatus.
Although the glycoproteins expressed from have been previously examined. We have found that
G2 from La Crosse contains appropriate signals forV V.MLacZ appeared to be targeted and processed ap-
propriately, the insertion of the LacZ peptide could Golgi targeting but G1 does not. Thus G2 – G1 associa-
tion is necessary for transport of the glycoprotein com-have resulted in more subtle alterations in their struc-
ture. In order to examine this possibility, we assayed plex to the site of viral assembly. For Bunyamwera,
Uukuniemi, and Punta Toro viruses, one of the twocells infected with this recombinant virus for pH-de-
pendent cell-to-cell fusion, a characteristic of the La glycoproteins can target to the Golgi apparatus inde-
pendently of the other (8, 10, 11, 20). The Hantaan virusCrosse glycoproteins (12). Following a 16-hr infection,
cells infected with V V.MLacZ or a control V V.tk0 (a glycoproteins may need to assemble into a heterodim-
eric complex in order to leave the endoplasmic reticu-recombinant vaccinia virus not expressing La Crosse
glycoproteins) were exposed to acidic conditions (pH lum (6), although one group has described indepen-
dent Golgi targeting for the Hantaan virus G1 (7). The5.8) for 30 sec and then incubated at 317. As previously
observed with V V.ORF (12), V V.MLacZ induced pH-de- sum of these studies indicates that there is no consis-
tent pattern as to the size of the glycoprotein that ispendent fusion that was well above the background
level of fusion observed with V V.tk 0 infected cells responsible for proper intracellular transport. Rather,
the critical issue seems to be the order of translation(not shown). This indicated that this functional property
of the La Crosse surface glycoproteins was not dis- in the ORF — the glycoprotein being translated first
containing the Golgi targeting signal. Not surprisingly,turbed by the LacZ insertion. Furthermore, as cell-to-
cell fusion is a property of glycoproteins expressed at as they are in the same genus, La Crosse virus is
similar to Bunyamwera (10), where the smaller of thethe cell surface, these results indicate that under these
conditions the glycoproteins are transported there. glycoproteins contains the information required for
transport.Because members of the Bunyaviridae assemble in
the Golgi apparatus (18, 19), the intracellular targeting In contrast to results with Bunyamwera, Hantaan, and
Uukuniemi viruses (6–8, 10, 11), we find that expressionproperties of the glycoproteins from several of them
AID VY 7967 / 6a18$$$521 05-17-96 00:30:09 vira AP: Virology
489SHORT COMMUNICATION
FIG. 5. G1 and G2 colocalize with WGA when expressed from VV.MLacZ. Cells infected with VV.MLacZ were fixed and stained as described in
Fig. 2. Both perinuclear anti-G1 (top left) and anti-G2 (top right) staining were very similar to WGA staining patterns in the same cells (bottom left
and bottom right, respectively).
of G1 and G2 from separate vectors does not lead to of the glycoproteins. This implies that NSm is not re-
quired for these functions.G1–G2 association. The difference may be due to the
fact that, among the N-terminal M segment glycoprotein The function of the nonstructural portion of the M seg-
ment translation product has not yet been determined.constructs employed in these studies, only the transla-
tion product of the G2 construct of La Crosse utilized here The localization of the Bunyamwera virus NSm product
to the Golgi apparatus (10, 21) suggests that it mightprecisely mimics the sequence of the mature protein at
play a catalytic role in virion formation. We are currentlyits C-terminus. Differences in C-terminal sequences may
developing a system for incorporating a mutated M seg-lead to differences in folding dynamics. The presence of
ment into La Crosse virions. When this becomes possi-a mature C-terminal sequence might allow rapid passage
ble, we will be able to directly test the importance of theto a mature folded state which may be incompatible with
NSm region in the viral life cycle. In the meantime, weG1 association when G1 is expressed separately. Dele-
are testing the limits of the sequence variability toleratedtion of a portion of the C-terminus (10) or addition of
in NSm both by deleting portions of the native sequencedownstream sequences (6–8, 11) might slow down the
and by inserting larger foreign segments.folding of the N-terminal protein. This could lengthen the
amount of time it spends in an association-competent
state, thus allowing more time for its interaction with the
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